| Previous close | 0.1950 |
| Open | 0.2100 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.2000 - 0.2100 |
| 52-week range | 0.1900 - 0.9946 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 28.576M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Increases to CEO Compensation Might Be Put On Hold For Now at SomnoMed Limited (ASX:SOM)
Key Insights SomnoMed to hold its Annual General Meeting on 24th of November Total pay for CEO Neil Verdal-Austin...
- Simply Wall St.
SomnoMed Full Year 2023 Earnings: Revenues In Line With Expectations
SomnoMed ( ASX:SOM ) Full Year 2023 Results Key Financial Results Revenue: AU$83.6m (up 15% from FY 2022). Net loss...
- Simply Wall St.
Investors in SomnoMed (ASX:SOM) have unfortunately lost 44% over the last five years
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
© 2024 Yahoo. All rights reserved.